Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Engineering and design considerations for next-generation snakebite antivenoms.

Knudsen C, Ledsgaard L, Dehli RI, Ahmadi S, Sørensen CV, Laustsen AH.

Toxicon. 2019 Sep;167:67-75. doi: 10.1016/j.toxicon.2019.06.005. Epub 2019 Jun 4. Review.

PMID:
31173790
2.

Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, Oscoz S, Slavny P, Griffiths DT, Luther AM, Leah RA, Lindholm M, Lomonte B, Gutiérrez JM, McCafferty J.

Nat Commun. 2018 Nov 20;9(1):4957. doi: 10.1038/s41467-018-07480-8.

3.

In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, Oscoz S, Slavny P, Griffiths DT, Luther AM, Leah RA, Lindholm M, Lomonte B, Gutiérrez JM, McCafferty J.

Nat Commun. 2018 Oct 2;9(1):3928. doi: 10.1038/s41467-018-06086-4. Erratum in: Nat Commun. 2018 Nov 20;9(1):4957.

4.

Recent Advances in Next Generation Snakebite Antivenoms.

Knudsen C, Laustsen AH.

Trop Med Infect Dis. 2018 Apr 15;3(2). pii: E42. doi: 10.3390/tropicalmed3020042. Review.

5.

Pros and cons of different therapeutic antibody formats for recombinant antivenom development.

Laustsen AH, María Gutiérrez J, Knudsen C, Johansen KH, Bermúdez-Méndez E, Cerni FA, Jürgensen JA, Ledsgaard L, Martos-Esteban A, Øhlenschlæger M, Pus U, Andersen MR, Lomonte B, Engmark M, Pucca MB.

Toxicon. 2018 May;146:151-175. doi: 10.1016/j.toxicon.2018.03.004. Epub 2018 Mar 10. Review.

Supplemental Content

Loading ...
Support Center